TickerFacts.

Insulet Corp (PODD): Cost of Revenue

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2014-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$768.20M
Year ended 2025-12-31
$883.20M
Trailing 12 months to 2026-06-30
+15.4%
3-year compound annual growth
+19.0%
5-year compound annual growth
+19.4%
10-year compound annual growth
2009-12-31: $47.73M2010-12-31: $53.24M2011-12-31: $85.54M2012-12-31: $119.03M2013-12-31: $134.68M2014-12-31: $104.19M2015-12-31: $130.62M2016-12-31: $155.90M2017-12-31: $186.60M2018-12-31: $193.60M2019-12-31: $257.90M2020-12-31: $322.10M2021-12-31: $346.70M2022-12-31: $499.70M2023-12-31: $537.20M2024-12-31: $625.90M2025-12-31: $768.20M$768.20M
2009-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$768.20M+22.7%2026-02-18, From 2025-01-01
2024-12-31$625.90M+16.5%2026-02-18, From 2024-01-01
2023-12-31$537.20M+7.5%2026-02-18, From 2023-01-01
2022-12-31$499.70M+44.1%2025-02-21, From 2022-01-01
2021-12-31$346.70M+7.6%2024-02-23, From 2021-01-01
2020-12-31$322.10M+24.9%2023-02-24, From 2020-01-01
2019-12-31$257.90M+33.2%2022-02-24, From 2019-01-01
2018-12-31$193.60M+3.8%2021-02-24, From 2018-01-01
2017-12-31$186.60M+19.7%2020-02-26, From 2017-01-01
2016-12-31$155.90M+19.4%2019-02-26, From 2016-01-01
2015-12-31$130.62M+25.4%2018-02-22, From 2015-01-01
2014-12-31$104.19Mn/c2017-02-28, From 2014-01-01
2013-12-31$134.68M+13.1%2016-02-29, From 2013-01-01
2012-12-31$119.03M+39.1%2015-02-26, From 2012-01-01
2011-12-31$85.54M+60.7%2014-02-28, From 2011-01-01
2010-12-31$53.24M+11.5%2013-02-28, From 2010-01-01
2009-12-31$47.73Mn/a2013-02-28, From 2009-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Insulet Corp (PODD)2025-12-31$768.20M+22.7%
Globus Medical Inc (GMED)2025-12-31$957.80M-7.5%
West Pharmaceutical Services Inc (WST)2025-12-31$1.97B+4.0%
MiniMed Group, Inc. (MMED)2026-04-24$1.42B+19.8%
ICU Medical Inc (ICUI)2025-12-31$1.41B-9.5%
Teleflex Inc (TFX)2025-12-31$871.96M+31.7%
Integra Lifesciences Holdings Corp (IART)2025-12-31$803.62M+10.3%
Dexcom Inc (DXCM)2025-12-31$1.86B+16.6%
Merit Medical Systems Inc (MMSI)2025-12-31$777.64M+9.0%

Compare PODD, GMED, WST, MMED side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗